July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The pro-cell death RIP1 kinase mediates angiogenesis by facilitating M2-like macrophages
Author Affiliations & Notes
  • Takashi Ueta
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
    University of Tokyo, Tokyo, Japan
  • Kenji Ishihara
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Shoji notomi
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Kyushu University, Fukuoka, Japan
  • Jong-Jer Lee
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Daniel Maidana
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nikolaos Efstathiou
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Yusuke Murakami
    Kyushu University, Fukuoka, Japan
  • Eiichi Hasegawa
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Kyushu University, Fukuoka, Japan
  • Joan W Miller
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios Vavvas
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Takashi Ueta, None; Kenji Ishihara, None; Shoji notomi, None; Jong-Jer Lee, None; Daniel Maidana, None; Nikolaos Efstathiou, None; Yusuke Murakami, None; Eiichi Hasegawa, None; Joan Miller, KalVista Pharmaceuticals (C), Maculogix (C), Massachusetts Eye and Ear/Valeant Pharmaceuticals (P), ONL Therapeutics (C); Demetrios Vavvas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 769. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takashi Ueta, Kenji Ishihara, Shoji notomi, Jong-Jer Lee, Daniel Maidana, Nikolaos Efstathiou, Yusuke Murakami, Eiichi Hasegawa, Joan W Miller, Demetrios Vavvas; The pro-cell death RIP1 kinase mediates angiogenesis by facilitating M2-like macrophages. Invest. Ophthalmol. Vis. Sci. 2018;59(9):769.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Angiogenesis, including choroidal neovascularization (CNV), has been implicated in diverse pathologies. Whereas multiple roles for receptor-interacting protein 1 (RIP1) in the regulation of apoptosis, necroptosis, and inflammation have been reported, its role in angiogenesis remains elusive.

Methods : The animal model of laser-induced CNV in mice was used for this study. Necrostatin-1 (Nec-1), GSK’872, and Z-VAD-FMK (Z-VAD) was intravitreally injected after CNV induction to inhibit RIP1 kinase, RIP3 kinase, and caspase activity, respectively. Kinase-inactive RIP1K45A/K45A knock-in mice and RIP3-/- mice were also used to assess the involvement of RIP1/RIP3 pathway in the development of laser-induced CNV. CNV size was evaluated after 7 days of CNV induction. Tissue samples of 4–5 days after CNV inductions were used to evaluate the effect of RIP kinases and caspase on the ongoing angiogenesis with infiltrated macrophages. Mouse bone marrow-derived macrophages (BMDMs) were polarized to M2 phenotype by IL-4 activation, and the effect of RIP1 kinase and caspase inhibition on polarization was evaluated.

Results : RIP1 protein expression was significantly up-regulated in CNV lesions with ongoing angiogenesis. Genetic or pharmacological inhibitions of RIP1 kinase as well as pharmacological inhibition of RIP3 kinase, but not total deletion of RIP3, attenuate angiogenesis in laser-induced CNV, suggesting a role for kinase independent function of RIP3 in the attenuation of CNV development. The catalytic inhibition of RIP1 activates caspases in infiltrating macrophages, thereby dampening CNV development. Furthermore, caspase activation by the catalytic inhibition of RIP1 suppressed the pro-angiogenic M2-like polarization in macrophages, while M1-like marker expressions were up-regulated.

Conclusions : These results suggest a novel, non-necrotic function of RIP kinases and suggest that RIP1-mediated modulation of macrophage activation may represent a therapeutic target for the control of angiogenesis-related diseases.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×